Dr. Philip M. Arlen to give scientific presentation at two conferences

Dr. Philip M Arlen, MD, President and CEO is Presenting the Following Talk at the 8th Annual Immuno-Oncology Virtual Summit, in the Neoantigen Targeted Therapies and Personalized Cancer Vaccines section, entitled: “Clinical Development of Monoclonal Antibodies Targeting Tumor Neoepitopes” on October 8, 2020; and at the Festival of Biologics World Immunotherapy Congress 2020, Basel, Switzerland, Live Digital, November 2 – 5, 2020.